Fang Fan

City of Hope
Country flagUnited States

Research Interests

ApplyKite TwinLearns as you apply

Make your next move.

Prepare your application

Review drafts before you send them.

Explore related searches

Articles (9)

Year:

2026

Year:

2026

Year:

2026

Residual Cancer Burden (RCB) after neoadjuvant chemotherapy (NAC) is validated to predict event-free survival (EFS) in breast cancer but has not been studied for invasive lobular carcinoma (ILC). We studied patient-level data from a pooled cohort across 12 institutions. Associations between RCB index, class, and EFS were assessed in ILC and non-ILC with mixed effect Cox models and multivariable analyses. Recursive partitioning was used in an exploratory model to stratify prognosis by RCB components. Of 5106 patients, the diagnosis was ILC in 216 and non-ILC in 4890. Increased RCB index was associated with worse EFS in both ILC and non-ILC ( p = 0.002 and p < 0.001, respectively) and remained prognostic when stratified by receptor subtype and adjusted for age, grade, T category, and nodal status. Recursive partitioning demonstrated residual invasive cancer cellularity as most prognostic in ILC. These results underscore the utility of RCB for evaluating NAC response in those with ILC.

Year:

2025

Year:

2025

Year:

2025

Year:

2023

Year:

2021

Year:

2020

Collaborators (6)

Min Han

Assistant Clinical Professor

City Of Hope National Medical Center

UNITED STATES
View details

Sara Lopez-Tarruella

ASSOCIATE PROFESSOR

Universidad Complutense de Madrid

SPAIN
View details

Jean Abraham

Professor of Precision Breast Cancer Medicine

University of Cambridge

UNITED KINGDOM
View details

Marick Laé

-

FRANCE
View details

Laura Esserman

University of California

UNITED STATES
View details

Rita A. Mukhtar

Professor of Surgery

University of California

UNITED STATES
View details